Paliperidon Teva (Paliperidone Palmitate)

Paliperidone Palmitate, the active ingredient in Paliperidon Teva, is an antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is employed in the maintenance treatment of schizophrenia in adult patients. GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Paliperidon Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Paliperidon Teva is an antipsychotic medication that acts within the central nervous system to manage psychotic disorders.

- Schizophrenia: helps maintain symptom control and reduce relapse risk in adults. - Schizoaffective disorder: contributes to stabilization of mood and psychotic symptoms. - Bipolar I disorder (maintenance): assists in preventing recurrence of manic or depressive episodes when used as part of a broader treatment plan.

Side effects reported with paliperidone palmitate vary in frequency and severity.

Common Side Effects: - Injection site pain or swelling. - Weight gain. - Fatigue or somnolence. - Restlessness (akathisia). - Constipation. - Dry mouth.

Serious or Rare Side Effects: - Neuroleptic malignant syndrome. - Tardive dyskinesia. - Severe orthostatic hypotension. - Elevated prolactin leading to galactorrhea or menstrual disturbances. - Seizure activity. - Significant QT‑interval prolongation. - Hyperglycaemia or new‑onset diabetes mellitus.

When prescribing Paliperidon Teva, clinicians should consider several safety aspects.

- Cardiovascular assessment: evaluate for history of arrhythmias or orthostatic hypotension. - Metabolic monitoring: track weight, glucose, and lipid profiles regularly. - Prolactin levels: monitor for signs of hyperprolactinaemia. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Elderly patients: start at lower doses and observe for sedation. - Store at room temperature: keep in original packaging, protect from moisture and direct light.

Paliperidon Teva may interact with other medicines, requiring careful review.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) – may increase paliperidone exposure. - CNS depressants (e.g., benzodiazepines, opioids) – additive sedation.

Moderate Interactions (Monitor Closely):\n- Antihypertensive agents – may enhance orthostatic hypotension. - Anticholinergic drugs – may worsen cognitive effects. - Medications that prolong QT interval – increase risk of cardiac arrhythmias. - CYP2D6 substrates – potential alteration of plasma levels. - Herbal supplements (e.g., St. John’s wort) – may affect metabolism.